Hepatits C and B in blood transfusion recipients indentified at Isfahan province

Journal of Isfahan Medical School

Volumn 29, Issue 139, 2011, Pages 615-620

  Kalantari, Hamid ^a   Mirzabaghi, Ahmad ^b   Akbari, Mojtaba ^b   Kalantari, Maryam ^c   Shahshahan, Zahra ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Blood transfusion recipient; Hemophilia; Thalassemia

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; BETA THALASSEMIA; BLOOD SAMPLING; BLOOD TRANSFUSION; CHILD; CHRONIC HEPATITIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FAMILY HISTORY; FEMALE; GENOTYPE; HEMOPHILIA; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; THALASSEMIA;

EID: 80052861885     PISSN: 10277595     EISSN: 1735854X     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusion-transmitted infections among multitransfused patients in Iran: a review. Transfus Med 2007; 17(6): 425-33.
2. Yee TT, Lee CA. Transfusion-transmitted infection in hemophilia in developing countries. Semin Thromb Hemost 2005; 31(5): 527-37.
3. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia 2007; 13(2): 156-63.
4. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327(7414): 557-60.
5. Burki MF, Hassan M, Hussain H, Nisar Y, Krishan J. Prevalence of anti-hepatitis C antibodies in multiply transfused beta thalassemia major patients. Ann Pak Inst Med Sci 2005; 1(3): 150-3.
6. Kalantari H, Rad N. Efficacy of interferon alpha-2b with or without ribavirin in thalassemia major patients with chronic hepatitis C virus infection: A randomized, double blind, controlled, parallel group trial. J Res Med Sci 2010; 15(6): 310-6.
7. Timan IS, Aulia D, Atmakusma D, Sudoyo A, Windiastuti E, Kosasih A. Some hematological problems in Indonesia. Int J Hematol 2002; 76(Suppl 1): 286-90.
8. Seme K, Poljak M, Begovac J, Vince A, Tomazic J, Vidmar L, et al. Low prevalence of hepatitis C virus infection among human immunodeficiency virus type 1-infected individuals from Slovenia and Croatia. Acta Virol 2002; 46(2): 91-4.
9. Wharfe G, Smikle M, Dowe G, Buchner L, Choo-Kang E, Graham S, et al. Seroprevalence of hepatitis C virus in haemophiliacs in Jamaica. Hum Antibodies 2002; 11(3): 61-4.
10. Fontes EM, Amorim L, Carvalho SM, Farah MB. Hemophilia care in the state of Rio de Janeiro, Brazil. Rev Panam Salud Publica 2003; 13(2-3): 124-8.
11. Barbosa AP, Martins RM, Teles SA, Silva SA, Oliveira JM, Yoshida CF. Prevalence of hepatitis C Virus infection among hemophiliacs in Central Brazil. Mem Inst Oswaldo Cruz 2002; 97(5): 643-4.
12. Javadzadeh H, Attar M, Taher Yavari M. Study of the prevalence of HBV, HCV, and HIV infection in hemophilia and thalassemia population of Yazd. Blood 2006; 2(7): 315-22.
13. Iranian Blood Transfusion Organization. Annual Reports. Tehran: Iranian Blood Transfusion.Organization; 2005